The competency of AREG mAb‐caused reversion of chemotherapy‐elicited changes in cancer cells was further supported by similar changes in several EMT‐specific markers (Figure S5e), data consistent with our findings from cancer cell‐based in vitro assays (Figure 4g,h; Figure S4e,f). This evidence concerns the gene AREG and cancer.